182 related articles for article (PubMed ID: 25060325)
21. Reappraisal of Serosal Invasion in Patients With T3 Colorectal Cancer by Elastic Stain: Clinicopathologic Study of 139 Surgical Cases With Special Reference to Peritoneal Elastic Lamina Invasion.
Nakanishi Y; LeVea C; Dibaj S; Habib F; Cheney R; Kanehira K
Arch Pathol Lab Med; 2016 Jan; 140(1):81-5. PubMed ID: 26717059
[TBL] [Abstract][Full Text] [Related]
22. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
23. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
[TBL] [Abstract][Full Text] [Related]
26. Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.
Elzagheid A; Emaetig F; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
Tumour Biol; 2013 Apr; 34(2):621-8. PubMed ID: 23179399
[TBL] [Abstract][Full Text] [Related]
27. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer.
Dai W; Meng X; Mo S; Xiang W; Xu Y; Zhang L; Wang R; Li Q; Cai G
Cell Commun Signal; 2020 Jan; 18(1):7. PubMed ID: 31918722
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca
Shi Y; Wang Y; Jiang H; Sun X; Xu H; Wei X; Wei Y; Xiao G; Song Z; Zhou F
Cell Death Dis; 2021 Sep; 12(9):837. PubMed ID: 34489398
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of locally or radically resected T1 colorectal cancer.
Nam MJ; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Kim SY; Baek JY; Park SC; Oh JH
Colorectal Dis; 2016 Sep; 18(9):852-60. PubMed ID: 26589573
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
31. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
32. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
33. The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.
Ogawa H; Nagano H; Konno M; Eguchi H; Koseki J; Kawamoto K; Nishida N; Colvin H; Tomokuni A; Tomimaru Y; Hama N; Wada H; Marubashi S; Kobayashi S; Mori M; Doki Y; Ishii H
Mol Clin Oncol; 2015 May; 3(3):563-571. PubMed ID: 26137268
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
36. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
[TBL] [Abstract][Full Text] [Related]
38. Pyruvate dehydrogenase E1α represents a reliable prognostic predictor for patients with non-small cell lung cancer resected via curative operation.
Ito R; Yashiro M; Tsukioka T; Izumi N; Komatsu H; Inoue H; Yamamoto Y; Nishiyama N
J Thorac Dis; 2021 Oct; 13(10):5691-5700. PubMed ID: 34795919
[TBL] [Abstract][Full Text] [Related]
39. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer.
Yoda Y; Ikematsu H; Matsuda T; Yamaguchi Y; Hotta K; Kobayashi N; Fujii T; Oono Y; Sakamoto T; Nakajima T; Takao M; Shinohara T; Fujimori T; Kaneko K; Saito Y
Endoscopy; 2013 Sep; 45(9):718-24. PubMed ID: 23918621
[TBL] [Abstract][Full Text] [Related]
40. Low expression of PDHA1 predicts poor prognosis in gastric cancer.
Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y
Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
